↓ Figure 1. Summary of the pathway for the eradication of CAD. This general overview begins with identifying individuals with unknown risk, followed by testing coronary CTA and AI-based plaque analysis, combined with genetic profiling using a polygenic risk score (PRS) to assess risk. The next step is personalized therapy, concluding with ongoing follow-up to prevent future events. AI: artificial intelligence; CAD: coronary artery disease; CTA: computed tomographic angiography.
